Jan 4 (Reuters) - Alexion Pharmaceuticals Inc on
Wednesday filed its delayed third-quarter 2016 financial report
with U.S. regulators and said an investigation into allegations
regarding sales practices found no need to restate previous
financial results.
Read more
No comments:
Post a Comment